SOUTH DAKOTA IMPLEMENTS STATEWIDE HYDROXYCHLOROQUINE CLINICAL TRIAL FOR POTENTIAL COVID TREATMENT

Apr 13, 2020 by

Explained: What Is Hydroxychloroquine, The Drug Touted As Cure To ...

4.13.20 – Fox News

“South Dakota implements statewide hydroxychloroquine clinical trial for potential coronavirus treatment”

By Brooke Singman | Fox News

https://www.foxnews.com/politics/south-dakota-implements-statewide-hydroxychloroquine-clinical-trial-for-coronavirus-treatment

Excerpts from this article:

EXCLUSIVE: South Dakota Gov. Kristi Noem on Monday announced a statewide clinical trial of hydroxychloroquine for the possible treatment of COVID-19, making her state the first in the country to institute a program exploring the potential effectiveness of the drug in treating and preventing coronavirus…

Noem, a Republican, announced the “comprehensive” clinical trial Monday after communicating with White House officials in the last week to “let them know that South Dakota’s medical community was ready to step up and lead the way on research efforts.”

“I made direct requests to President Trump and Vice President Pence to supply us with enough hydroxychloroquine so that it could be made available for every hospitalized person the state may have, as well as those for health care workers on the frontlines and those in the most vulnerable populations,” Noem said.

The governor said South Dakota has received doses of hydroxychloroquine to begin the trial.

“Today, I’m pleased to report we have received the initial doses we need, and thanks to the leadership of Sanford Health and the assistance of medical teams at Avera and Monument Health, we’re going to be the first state in the nation to do a comprehensive clinical trial to assess whether hydroxychloroquine can treat and perhaps even prevent COVID-19,” she said.

Sanford Health is the largest provider of rural health care in the country, according to Noem. With the help of Avera and Monument Health, they will treat “up to 100,000 people including outpatient and hospitalized patients with COVID-19, in addition to frontline health care workers, and high-risk individuals who have been exposed to the virus.”

“The health care community in South Dakota consistently works together with the state for the benefit of all our patients,” South Dakota Secretary of Health Kim Malsam-Rysdon said Monday. “I am excited patients across the state will have access to this drug, and we will learn more about its benefits in treating and even preventing COVID-19.”

The drug has been a source of political controversy as President Trump has repeatedly touted it as a possible treatment for COVID-19…

South Dakota’s announcement comes days after the National Institutes of Health said it would run a human clinical trial for hydroxychloroquine, which typically serves as an antimalarial drug, as an option to treat patients with COVID-19. The trial, which started last week, began with 500 adult participants enrolled at Vanderbilt University Medical Center in Nashville, Tenn.

The trial is placebo-controlled and randomized, meaning some of the patients will be treated with hydroxychloroquine while others will not. However, “all participants in the study will continue to receive clinical care as indicated for their condition,” the NIH said.

Theoretically, the drug, with its ability to quiet an immune system response, could help prevent a COVID-19-infected person’s immune system from going into overdrive, attacking the virus so vigorously that it ultimately causes organ failure and death, as has occurred in some patients.

Though preliminary studies have shown the drug protects lab-grown cells from the virus, the human clinical trial is aimed at evaluating its “safety and effectiveness” in treating coronavirus patients, according to the NIH.

<< snip >>

Print Friendly, PDF & Email

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.